FDA Incident Reporting Conference
This article was originally published in The Gray Sheet
Executive SummaryAgency meeting health professional organizations on May 4 in Washington, D.C. in preparation for a medical products incident reporting conference on June 3, FDA announces April 22 in the Federal Register. FDA is holding the "premeeting" to discuss steps the health organizations can take to inform members about the agency's reporting programs. The session will include a presentation by FDA Commissioner David Kessler of the agency's incident reporting educational plans. The June 3 conference will include discussion of a device/drug/biologic reporting form under development at the agency ("The Gray Sheet" April 19, p. 21).
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.